Adage Capital Partners Gp, L.L.C. 89bio, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$59.7 Billion
Q3 2025

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in 89bio, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 9,097,587 shares of ETNB stock, worth $135 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

9,097,587

Previous 1,969,000 362.04%

Holding current value

$135 Million

Previous $19.3 Million 590.73%

% of portfolio

0.22%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$8.02 - $14.96 $57.2 Million - $107 Million	7,128,587 Added 362.04%	9,097,587 $134 Million
Q2 2025 Aug 14, 2025	BUY	$4.83 - $10.57 $9.51 Million - $20.8 Million	1,969,000 New	1,969,000 $19.3 Million
Q4 2024 Feb 14, 2025	SELL	$7.03 - $10.05 $3.69 Million - $5.28 Million	-525,000 Reduced 60.0%	350,000 $2.68 Million
Q3 2024 Nov 14, 2024	BUY	$7.36 - $9.66 $3.5 Million - $4.59 Million	475,000 Added 118.75%	875,000 $6.48 Million
Q2 2024 Aug 14, 2024	SELL	$7.31 - $10.9 $365,500 - $545,000	-50,000 Reduced 11.11%	400,000 $3.2 Million
Q1 2024 May 15, 2024	SELL	$8.13 - $13.77 $21.7 Million - $36.8 Million	-2,675,000 Reduced 85.6%	450,000 $5.24 Million
Q4 2023 Feb 14, 2024	BUY	$6.66 - $16.03 $9.5 Million - $22.9 Million	1,426,583 Added 83.99%	3,125,000 $34.9 Million
Q3 2023 Nov 14, 2023	BUY	$15.06 - $19.41 $4.1 Million - $5.28 Million	272,255 Added 19.09%	1,698,417 $26.2 Million
Q2 2023 Aug 14, 2023	SELL	$14.15 - $22.03 $24.7 Million - $38.5 Million	-1,748,838 Reduced 55.08%	1,426,162 $27 Million
Q1 2023 May 15, 2023	BUY	$10.48 - $16.94 $12.4 Million - $20.1 Million	1,187,408 Added 59.74%	3,175,000 $48.4 Million
Q4 2022 Feb 14, 2023	SELL	$5.52 - $12.73 $1.45 Million - $3.34 Million	-262,408 Reduced 11.66%	1,987,592 $25.3 Million
Q3 2022 Nov 14, 2022	BUY	$3.02 - $7.0 $3.47 Million - $8.05 Million	1,150,000 Added 104.55%	2,250,000 $13 Million
Q2 2022 Aug 15, 2022	BUY	$2.09 - $4.02 $2.3 Million - $4.42 Million	1,100,000 New	1,100,000 $3.54 Million

Others Institutions Holding ETNB

# of Institutions

223

Shares Held

157M

Call Options Held

729K

Put Options Held

5.84M

View Full List

About 89bio, Inc.

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $690M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

More about ETNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. 89bio, Inc. Transaction History